Author: National Research Council
Publisher: National Academies Press
ISBN: 0309075505
Category : Medical
Languages : en
Pages : 34
Book Description
X-ray mammography screening is the current mainstay for early breast cancer detection. It has been proven to detect breast cancer at an earlier stage and to reduce the number of women dying from the disease. However, it has a number of limitations. These current limitations in early breast cancer detection technology are driving a surge of new technological developments, from modifications of x-ray mammography such as computer programs that can indicate suspicious areas, to newer methods of detection such as magnetic resonance imaging (MRI) or biochemical tests on breast fluids. To explore the merits and drawbacks of these new breast cancer detection techniques, the Institute of Medicine of the National Academy of Sciences convened a committee of experts. During its year of operation, the committee examined the peer-reviewed literature, consulted with other experts in the field, and held two public workshops. In addition to identifying promising new technologies for early detection, the committee explored potential barriers that might prevent the development of new detection methods and their common usage. Such barriers could include lack of funding from agencies that support research and lack of investment in the commercial sector; complicated, inconsistent, or unpredictable federal regulations; inadequate insurance reimbursement; and limited access to or unacceptability of breast cancer detection technology for women and their doctors. Based on the findings of their study, the committee prepared a report entitled Mammography and Beyond: Developing Technology for Early Detection of Breast Cancer, which was published in the spring of 2001. This is a non-technical summary of that report.
Mammography and Beyond
Author: National Research Council
Publisher: National Academies Press
ISBN: 0309075505
Category : Medical
Languages : en
Pages : 34
Book Description
X-ray mammography screening is the current mainstay for early breast cancer detection. It has been proven to detect breast cancer at an earlier stage and to reduce the number of women dying from the disease. However, it has a number of limitations. These current limitations in early breast cancer detection technology are driving a surge of new technological developments, from modifications of x-ray mammography such as computer programs that can indicate suspicious areas, to newer methods of detection such as magnetic resonance imaging (MRI) or biochemical tests on breast fluids. To explore the merits and drawbacks of these new breast cancer detection techniques, the Institute of Medicine of the National Academy of Sciences convened a committee of experts. During its year of operation, the committee examined the peer-reviewed literature, consulted with other experts in the field, and held two public workshops. In addition to identifying promising new technologies for early detection, the committee explored potential barriers that might prevent the development of new detection methods and their common usage. Such barriers could include lack of funding from agencies that support research and lack of investment in the commercial sector; complicated, inconsistent, or unpredictable federal regulations; inadequate insurance reimbursement; and limited access to or unacceptability of breast cancer detection technology for women and their doctors. Based on the findings of their study, the committee prepared a report entitled Mammography and Beyond: Developing Technology for Early Detection of Breast Cancer, which was published in the spring of 2001. This is a non-technical summary of that report.
Publisher: National Academies Press
ISBN: 0309075505
Category : Medical
Languages : en
Pages : 34
Book Description
X-ray mammography screening is the current mainstay for early breast cancer detection. It has been proven to detect breast cancer at an earlier stage and to reduce the number of women dying from the disease. However, it has a number of limitations. These current limitations in early breast cancer detection technology are driving a surge of new technological developments, from modifications of x-ray mammography such as computer programs that can indicate suspicious areas, to newer methods of detection such as magnetic resonance imaging (MRI) or biochemical tests on breast fluids. To explore the merits and drawbacks of these new breast cancer detection techniques, the Institute of Medicine of the National Academy of Sciences convened a committee of experts. During its year of operation, the committee examined the peer-reviewed literature, consulted with other experts in the field, and held two public workshops. In addition to identifying promising new technologies for early detection, the committee explored potential barriers that might prevent the development of new detection methods and their common usage. Such barriers could include lack of funding from agencies that support research and lack of investment in the commercial sector; complicated, inconsistent, or unpredictable federal regulations; inadequate insurance reimbursement; and limited access to or unacceptability of breast cancer detection technology for women and their doctors. Based on the findings of their study, the committee prepared a report entitled Mammography and Beyond: Developing Technology for Early Detection of Breast Cancer, which was published in the spring of 2001. This is a non-technical summary of that report.
Tumor Marker and Carcinogenesis
Author: Manjul Tiwari
Publisher: CRC Press
ISBN: 1000819124
Category : Medical
Languages : en
Pages : 98
Book Description
Cancer may be regarded as a group of diseases characterized by an (i) abnormal growth of cells (ii) ability to invade adjacent tissue and even distant organs and(iii) the eventual death of the affected patient if the tumor has progressed beyond that stage when it can be successfully removed.
Publisher: CRC Press
ISBN: 1000819124
Category : Medical
Languages : en
Pages : 98
Book Description
Cancer may be regarded as a group of diseases characterized by an (i) abnormal growth of cells (ii) ability to invade adjacent tissue and even distant organs and(iii) the eventual death of the affected patient if the tumor has progressed beyond that stage when it can be successfully removed.
Serological Cancer Markers
Author: Stewart Sell
Publisher: Springer Science & Business Media
ISBN: 1461204011
Category : Medical
Languages : en
Pages : 537
Book Description
The purpose of this book-the fourth volume of a series on Can cer Markers-is intended to provide an updated "status report" on today's use of cancer markers in the diagnosis and monitoring of can cer, with an emphasis on cancer markers detected in the serum. It has been 7 years since the publication of the last volume in this series. The 1980, 1982, and 1985 volumes covered the development of cancer markers, not only in their roles of unraveling the basic biology of can cer, but also as increasingly important players in the management of patients with cancer. During the last 7 years we have seen the applica tion of a number of markers identified by monoclonal antibodies, as well as the beginnings of the use of genetic markers defined by mo lecular probes. Measurements of oncogenes in tissues or cells prom ise many applications for the future, but as yet, these genes have not shown to be useful as serum markers of cancer. The commercial interest in serum markers for cancer, particu larly for the diagnosis and monitoring of tumor patients, is indicated in Chapter 24 by Owen, where the total worldwide market for cancer markers is projected to increase from $148 million in 1988 to $232 million in 1993. The degree of research interest in cancer markers is reflected in the fact that in 1988 a separate category for tumor mark ers was added to Index Medicus.
Publisher: Springer Science & Business Media
ISBN: 1461204011
Category : Medical
Languages : en
Pages : 537
Book Description
The purpose of this book-the fourth volume of a series on Can cer Markers-is intended to provide an updated "status report" on today's use of cancer markers in the diagnosis and monitoring of can cer, with an emphasis on cancer markers detected in the serum. It has been 7 years since the publication of the last volume in this series. The 1980, 1982, and 1985 volumes covered the development of cancer markers, not only in their roles of unraveling the basic biology of can cer, but also as increasingly important players in the management of patients with cancer. During the last 7 years we have seen the applica tion of a number of markers identified by monoclonal antibodies, as well as the beginnings of the use of genetic markers defined by mo lecular probes. Measurements of oncogenes in tissues or cells prom ise many applications for the future, but as yet, these genes have not shown to be useful as serum markers of cancer. The commercial interest in serum markers for cancer, particu larly for the diagnosis and monitoring of tumor patients, is indicated in Chapter 24 by Owen, where the total worldwide market for cancer markers is projected to increase from $148 million in 1988 to $232 million in 1993. The degree of research interest in cancer markers is reflected in the fact that in 1988 a separate category for tumor mark ers was added to Index Medicus.
Role of Biomarkers in Medicine
Author: Mu Wang
Publisher: BoD – Books on Demand
ISBN: 9535125052
Category : Medical
Languages : en
Pages : 262
Book Description
The use of biomarkers in basic and clinical research has become routine in many areas of medicine. They are accepted as molecular signatures that have been well characterized and repeatedly shown to be capable of predicting relevant disease states or clinical outcomes. In Role of Biomarkers in Medicine, expert researchers in their individual field have reviewed many biomarkers or potential biomarkers in various types of diseases. The topics address numerous aspects of medicine, demonstrating the current conceptual status of biomarkers as clinical tools and as surrogate endpoints in clinical research. This book highlights the current state of biomarkers and will aid scientists and clinicians to develop better and more specific biomarkers for disease management.
Publisher: BoD – Books on Demand
ISBN: 9535125052
Category : Medical
Languages : en
Pages : 262
Book Description
The use of biomarkers in basic and clinical research has become routine in many areas of medicine. They are accepted as molecular signatures that have been well characterized and repeatedly shown to be capable of predicting relevant disease states or clinical outcomes. In Role of Biomarkers in Medicine, expert researchers in their individual field have reviewed many biomarkers or potential biomarkers in various types of diseases. The topics address numerous aspects of medicine, demonstrating the current conceptual status of biomarkers as clinical tools and as surrogate endpoints in clinical research. This book highlights the current state of biomarkers and will aid scientists and clinicians to develop better and more specific biomarkers for disease management.
Bladder Cancer
Author: M Hammad Ather
Publisher: BoD – Books on Demand
ISBN: 9535130773
Category : Medical
Languages : en
Pages : 138
Book Description
Bladder cancer is one of the most exciting urological cancers. It exists in two forms - non-muscle-invasive (NMI) and muscle-invasive (MI) disease. The difference in the clinical picture has been the focus of significant research in defining the molecular characteristics of urothelial cancer (UC) of the bladder. This book provides an overview of the most hotly debated areas in bladder cancer. Authors have focused on the emerging role of markers for NMI UC and various ways of improving the efficacy of current chemotherapy in the first section. The second section has focused on the surgical aspects of MI UC. Two major areas of debate - the role of pelvic lymph node dissection and genital sparing surgery - are discussed in this section.
Publisher: BoD – Books on Demand
ISBN: 9535130773
Category : Medical
Languages : en
Pages : 138
Book Description
Bladder cancer is one of the most exciting urological cancers. It exists in two forms - non-muscle-invasive (NMI) and muscle-invasive (MI) disease. The difference in the clinical picture has been the focus of significant research in defining the molecular characteristics of urothelial cancer (UC) of the bladder. This book provides an overview of the most hotly debated areas in bladder cancer. Authors have focused on the emerging role of markers for NMI UC and various ways of improving the efficacy of current chemotherapy in the first section. The second section has focused on the surgical aspects of MI UC. Two major areas of debate - the role of pelvic lymph node dissection and genital sparing surgery - are discussed in this section.
Accurate Results in the Clinical Laboratory
Author: Amitava Dasgupta
Publisher: Elsevier
ISBN: 0128137770
Category : Science
Languages : en
Pages : 512
Book Description
Accurate Results in the Clinical Laboratory: A Guide to Error Detection and Correction, Second Edition, provides a comprehensive review of the factors leading to errors in all areas of clinical laboratory testing. This trusted guide addresses interference issues in all laboratory tests, including patient epigenetics, processes of specimen collection, enzymes and biomarkers. Clinicians and laboratory scientists will both benefit from this reference that applies discussions to both accurate specimen analysis and optimal patient care. Hence, this is the perfect reference for clinical laboratorians, from trainees, to experienced pathologists and directors. - Provides comprehensive coverage across endocrine, oncology, hematology, immunohistochemistry, immunology, serology, microbiology, and molecular testing - Includes new case studies that highlight clinical relevance and errors to avoid - Highlights the best titles published within a variety of medical specialties - Reviewed by medical librarians and content specialists, with key selections compiled in their annual list
Publisher: Elsevier
ISBN: 0128137770
Category : Science
Languages : en
Pages : 512
Book Description
Accurate Results in the Clinical Laboratory: A Guide to Error Detection and Correction, Second Edition, provides a comprehensive review of the factors leading to errors in all areas of clinical laboratory testing. This trusted guide addresses interference issues in all laboratory tests, including patient epigenetics, processes of specimen collection, enzymes and biomarkers. Clinicians and laboratory scientists will both benefit from this reference that applies discussions to both accurate specimen analysis and optimal patient care. Hence, this is the perfect reference for clinical laboratorians, from trainees, to experienced pathologists and directors. - Provides comprehensive coverage across endocrine, oncology, hematology, immunohistochemistry, immunology, serology, microbiology, and molecular testing - Includes new case studies that highlight clinical relevance and errors to avoid - Highlights the best titles published within a variety of medical specialties - Reviewed by medical librarians and content specialists, with key selections compiled in their annual list
Systems Biology of Cancer
Author: Sam Thiagalingam
Publisher: Cambridge University Press
ISBN: 0521493390
Category : Mathematics
Languages : en
Pages : 597
Book Description
An overview of the current systems biology-based knowledge and the experimental approaches for deciphering the biological basis of cancer.
Publisher: Cambridge University Press
ISBN: 0521493390
Category : Mathematics
Languages : en
Pages : 597
Book Description
An overview of the current systems biology-based knowledge and the experimental approaches for deciphering the biological basis of cancer.
TNM-Atlas
Author: Bernd Spiessl
Publisher: Springer Science & Business Media
ISBN: 3662024438
Category : Medical
Languages : en
Pages : 282
Book Description
Confronted with a myriad ofT's, N's and M's in the VICC TNM booklet, classifying a malignancy may seem to many cancer clini cians a tedious, dull and pedantic task. But at a closer look at the TNM Atlas all of a sudden lifeless categories become vivid im ages, challenging the clinician's know-how and investigational skills. Brigit van der Werf-Messing, M.D. Professor of Radiology Past Chairman of the International TNM-Committee of the VICC Rotterdam, July 1982 Preface In 1938 the League of Nations Health Organization published an Atlas Illustrating the Division of Cancer of the Uterine Cervix into Four Stages (J. Heyman, ed., Stockholm). Since this work appeared, the idea of visual representation of the anatomical ex tent of malignant tumours at the different stages of their develop ment has been repeatedly discussed. At its meeting in Copenhagen in July 1954, the DICC adopted as part of its programme "the realization of a clinical atlas". How ever, the time to do the planned book of illustrations was not ripe until the national committees and international organizations had officially recognized the 28 classifications of malignant tu mours at various sites as presented in the third edition of the TNM Booklet edited by M. Harmer (TNM Classification of Malig nant Tumours, 1978). This was all the more important since publi cation of the Booklet was followed in 1980 by publication of a Brochure of Checklists, edited by A.H.
Publisher: Springer Science & Business Media
ISBN: 3662024438
Category : Medical
Languages : en
Pages : 282
Book Description
Confronted with a myriad ofT's, N's and M's in the VICC TNM booklet, classifying a malignancy may seem to many cancer clini cians a tedious, dull and pedantic task. But at a closer look at the TNM Atlas all of a sudden lifeless categories become vivid im ages, challenging the clinician's know-how and investigational skills. Brigit van der Werf-Messing, M.D. Professor of Radiology Past Chairman of the International TNM-Committee of the VICC Rotterdam, July 1982 Preface In 1938 the League of Nations Health Organization published an Atlas Illustrating the Division of Cancer of the Uterine Cervix into Four Stages (J. Heyman, ed., Stockholm). Since this work appeared, the idea of visual representation of the anatomical ex tent of malignant tumours at the different stages of their develop ment has been repeatedly discussed. At its meeting in Copenhagen in July 1954, the DICC adopted as part of its programme "the realization of a clinical atlas". How ever, the time to do the planned book of illustrations was not ripe until the national committees and international organizations had officially recognized the 28 classifications of malignant tu mours at various sites as presented in the third edition of the TNM Booklet edited by M. Harmer (TNM Classification of Malig nant Tumours, 1978). This was all the more important since publi cation of the Booklet was followed in 1980 by publication of a Brochure of Checklists, edited by A.H.
MicroRNAs in Cancer
Author: Cesar Lopez-Camarillo
Publisher: CRC Press
ISBN: 1466576774
Category : Medical
Languages : en
Pages : 426
Book Description
MicroRNA (miRNA) biology is a cutting-edge topic in basic as well as biomedical research. This is a specialized book focusing on the current understanding of the role of miRNAs in the development, progression, invasion, and metastasis of diverse types of cancer. It also reviews their potential for applications in cancer diagnosis, prognosis, and th
Publisher: CRC Press
ISBN: 1466576774
Category : Medical
Languages : en
Pages : 426
Book Description
MicroRNA (miRNA) biology is a cutting-edge topic in basic as well as biomedical research. This is a specialized book focusing on the current understanding of the role of miRNAs in the development, progression, invasion, and metastasis of diverse types of cancer. It also reviews their potential for applications in cancer diagnosis, prognosis, and th
Comprehensive Diagnostic Approach to Bladder Cancer
Author: Marc A. Bjurlin
Publisher: Springer Nature
ISBN: 3030820483
Category : Medical
Languages : en
Pages : 232
Book Description
This succinct yet comprehensive book describes current and emerging concepts in risk stratification, detection, and staging of bladder cancer. Divided into two distinct sections, the first section focuses on contemporary and novel imaging modalities in bladder cancer staging. The second section illuminates advanced optical techniques and tumor markers for bladder cancer detection. The volume also addresses such topics as novel immuno-positron emission tomography radiotracers, imaging modalities for monitoring of tumor response, and non-invasive urine biomarkers such as current and emerging molecular markers for bladder cancer screening, early diagnosis, and surveillance. Comprehensive Diagnostic Approach to Bladder Cancer: Molecular Imaging and Biomarkers is written by experts in the field and provides a valuable resource for urologists, oncologists, urologic oncologists, radiation oncologists, allied health professionals, residents, and fellows who treat and manage bladder cancer.
Publisher: Springer Nature
ISBN: 3030820483
Category : Medical
Languages : en
Pages : 232
Book Description
This succinct yet comprehensive book describes current and emerging concepts in risk stratification, detection, and staging of bladder cancer. Divided into two distinct sections, the first section focuses on contemporary and novel imaging modalities in bladder cancer staging. The second section illuminates advanced optical techniques and tumor markers for bladder cancer detection. The volume also addresses such topics as novel immuno-positron emission tomography radiotracers, imaging modalities for monitoring of tumor response, and non-invasive urine biomarkers such as current and emerging molecular markers for bladder cancer screening, early diagnosis, and surveillance. Comprehensive Diagnostic Approach to Bladder Cancer: Molecular Imaging and Biomarkers is written by experts in the field and provides a valuable resource for urologists, oncologists, urologic oncologists, radiation oncologists, allied health professionals, residents, and fellows who treat and manage bladder cancer.